BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8317031)

  • 1. [Cervical cytological diagnosis of carcinoma].
    Van Nga P; Arffmann E
    Ugeskr Laeger; 1993 Jun; 155(23):1797-801. PubMed ID: 8317031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-positive squamous cell carcinoma in cervical smears: cytologic-histologic correlation in 19 cases.
    Levine PH; Elgert PA; Mittal K
    Diagn Cytopathol; 2003 Jan; 28(1):23-7. PubMed ID: 12508178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
    Chacho MS; Mattie ME; Schwartz PE
    Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAP smear after radiation therapy for cervical carcinoma.
    Rintala MA; Rantanen VT; Salmi TA; Klemi PJ; Grénman SE
    Anticancer Res; 1997; 17(5B):3747-50. PubMed ID: 9427773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of cervical cancer: the place of the cytological smear test.
    Hudson E
    Clin Obstet Gynaecol; 1985 Mar; 12(1):33-51. PubMed ID: 3888487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
    Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory reliability of the Papanicolaou smear.
    Yobs AR; Swanson RA; Lamotte LC
    Obstet Gynecol; 1985 Feb; 65(2):235-44. PubMed ID: 3969236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytology in the diagnosis and follow-up of patients with cervical adenocarcinoma.
    Saigo PE; Wolinska WH; Kim WS; Hajdu SI
    Acta Cytol; 1985; 29(5):785-94. PubMed ID: 3863425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exfoliative cytology of microinvasive squamous-cell carcinoma of the uterine cervix. A retrospective study of 42 cases.
    Nguyen GK
    Acta Cytol; 1984; 28(4):457-60. PubMed ID: 6589925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [False negative Pap smears in a Danish material].
    Ejersbo D; Dahl MB; Hølund B
    Ugeskr Laeger; 2003 Jun; 165(23):2391-4. PubMed ID: 12840998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
    Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
    Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytology of microinvasive squamous-cell carcinoma of the uterine cervix.
    Sugimori H; Iwasaka T; Yoshimura T; Tsukamoto N
    Acta Cytol; 1987; 31(4):412-6. PubMed ID: 3604535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.
    Silfverdal L; Kemetli L; Andrae B; Sparén P; Ryd W; Dillner J; Strander B; Törnberg S
    Am J Obstet Gynecol; 2009 Aug; 201(2):188.e1-7. PubMed ID: 19560117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Foundations for differential cytology of cervical changes. 3. Dysplasia and carcinoma in situ (author's transl)].
    Höffken H; Rummel HH
    Zentralbl Gynakol; 1981; 103(24):1517-36. PubMed ID: 7340303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.